Yes, magnesium sulfate can be administered during spinal anesthesia and has demonstrated analgesic benefits.
Magnesium sulfate can be safely given via multiple routes during spinal anesthesia—including intrathecal (added to the spinal injection), intravenous infusion, or epidural administration—with evidence supporting improved postoperative analgesia and reduced opioid requirements.
Routes of Administration and Evidence
Intrathecal (Neuraxial) Magnesium
The 2021 PROSPECT guidelines for caesarean section explicitly support intrathecal magnesium sulfate use. A meta-analysis demonstrated that neuraxial magnesium produces longer duration of sensory block, lower pain scores, and reduced rescue analgesic requirements compared to local anesthetic alone 1. When combined with intrathecal dexmedetomidine or morphine, magnesium provides synergistic analgesia of longer duration 1.
Typical intrathecal dose: 50 mg magnesium sulfate added to the local anesthetic solution 2.
Intravenous Magnesium During Spinal Anesthesia
IV magnesium can be administered as an adjunct during spinal anesthesia with proven benefits:
- Dosing regimen: 50 mg/kg loading dose over 15 minutes, followed by 15 mg/kg/hour infusion until surgery completion 3, OR 65 mg/kg infusion over the operative period 4
- Alternative protocol: 250 mg bolus followed by 500 mg infusion at 20 mL/hour 5
Studies demonstrate that IV magnesium during spinal anesthesia:
- Prolongs sensory block duration by approximately 30-40 minutes 4
- Reduces postoperative pain scores at 2-6 hours 3, 4
- Decreases rescue analgesic requirements by 33-38% 5
- Delays need for rescue analgesia by nearly 3 hours 5
Combined Intrathecal and Epidural Approach
The most robust analgesic effect comes from combined intrathecal (94.5 mg, 6.3%) plus epidural (2%, 100 mg/hour) magnesium, which reduced postoperative morphine consumption by 69% at 36 hours compared to spinal anesthesia alone 6.
Safety Considerations and Monitoring
Critical Monitoring Parameters (FDA Label Requirements)
Per FDA labeling 7:
- Patellar reflex (knee jerk) must be present before each dose
- Respiratory rate ≥16 breaths/minute
- Serum magnesium levels: Therapeutic range 2.5-5 mEq/L (3-6 mg/100 mL)
- Deep tendon reflexes diminish when magnesium exceeds 4 mEq/L
- Reflexes absent at 10 mEq/L with risk of respiratory paralysis
Drug Interactions During Spinal Anesthesia
Important caution: Magnesium potentiates neuromuscular blocking agents—use concomitantly with extreme caution 7. The additive CNS depressant effects require dose adjustment of opioids, benzodiazepines, or other sedatives 7.
Contraindications Specific to Neuraxial Use
The 2022 WSES emergency surgery guidelines explicitly state: "Neuraxial administration of magnesium, benzodiazepines, neostigmine, tramadol, and ketamine should be avoided" (strong recommendation) 8.
However, this conflicts with the 2021 PROSPECT caesarean section guidelines that support intrathecal magnesium based on meta-analysis evidence 1. The key distinction is that the WSES guideline addresses emergency general surgery broadly, while PROSPECT specifically evaluated caesarean section with robust supporting data.
Clinical Context: When to Use
Proceed with intrathecal or IV magnesium when:
- Performing elective surgery under spinal anesthesia (particularly caesarean section, orthopedic surgery, or abdominal hysterectomy)
- Multimodal analgesia is employed
- Patient has normal renal function (magnesium eliminated solely by kidneys)
- Urine output maintained >100 mL/4 hours 7
Exercise extreme caution or avoid in:
- Renal impairment (reduce dose; maximum 20 g in 48 hours in severe impairment) 7
- Digitalized patients (risk of heart block) 7
- Pregnancy >5-7 days continuous use (fetal skeletal abnormalities) 7
- Concurrent neuromuscular blockade 7
Practical Algorithm
- Confirm eligibility: Normal renal function, no contraindications
- Choose route based on surgery type:
- Caesarean section: Intrathecal 50 mg OR IV 50 mg/kg load + 15 mg/kg/hr
- Major orthopedic: Combined intrathecal (94.5 mg) + epidural (100 mg/hr)
- Abdominal hysterectomy: IV 65 mg/kg over operative period
- Monitor: Patellar reflex, respiratory rate, serum magnesium if prolonged infusion
- Have calcium gluconate immediately available as antidote 7
Common Pitfalls
- Delayed sensory block onset: One study showed intrathecal magnesium delayed sensory blockade in caesarean section without meaningful analgesic benefit 2—this represents the minority finding but highlights individual variability
- Inadequate monitoring: Failure to check reflexes and respiratory status risks magnesium toxicity
- Renal dysfunction: Magnesium accumulates rapidly without dose adjustment
- Mixing with contraindicated neuraxial drugs: Avoid combining with midazolam, neostigmine, or tramadol intrathecally
The evidence strongly supports magnesium sulfate use during spinal anesthesia, particularly via IV route, with intrathecal administration showing promise in specific contexts like caesarean delivery when part of multimodal analgesia.